A Review of Repercussions of Lithium Amalgamated with Antipsychotics for the Remedy of Bipolar Disorder
Abstract
Bipolar disorder is a brain illness that causes mood, energy, and ability to function variations. Bipolar illness patients have extreme emotional states that often occur over a period of days to weeks, referred to as mood episodes. Manic/hypomanic (abnormally cheerful or angry mood) or depressed (sad mood) mood episodes are classified. People with bipolar disorder frequently have periods of neutral mood. People with bipolar disorder can live long and productive lives if they are treated. The management of BD may be summarized into 2 phases, acute treatment and long-term prevention. Lithium was observed to have a unique therapeutic profile, including mood-stabilizing effects, as well as anti-suicidal and neuroprotective properties.13 It is available in many different salt forms, namely lithium carbonate, lithium citrate, lithium chloride, and lithium sulfate. A meta-analysis discovered that a combination regimen of haloperidol, olanzapine, risperidone, and quetiapine was substantially more effective in treating BD manic episodes than monotherapy with a mood stabiliser, but the combination regimen was less well tolerated than monotherapy.
Keywords: Bipolar Disorder, Lithium, Monotherapy, Combination therapy, Adverse effects.
Keywords:
Bipolar Disorder, Lithium, Monotherapy, Combination therapy, Adverse effectsDOI
https://doi.org/10.22270/jddt.v13i5.6064References
Marneros JA. Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord. 2000; 67:3-19. https://doi.org/10.1016/S0165-0327(01)00429-3
Sansone RA, Sansone LA. Managing bipolar disorder in the primary care setting: a perspective for mental health professionals. Innov Clin Neurosci. 2011; 8(10):10-13.
Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005; 18(4):233-239. https://doi.org/10.3122/jabfm.18.4.233
Baldessarini RJ, Tondo L, Vazquez GH, et al. Age at onset versus family history and clinical outcomes in 1665 international bipolar-I disorder patients. World Psychiatry. 2012; 11(1):40-46. https://doi.org/10.1016/j.wpsyc.2012.01.006
Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013; 15(1):1-44. https://doi.org/10.1111/bdi.12025
Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol CJASN. 2015; 10:875-87. https://doi.org/10.2215/CJN.10021014
Fieve RR. Lithium therapy at the millennium: A revolutionary drug use for 50 years faces competing options and possible demise. Bipolar Disorder 1999; 1:67-70. https://doi.org/10.1034/j.1399-5618.1999.010201.x
Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007; 64(4):442-455. https://doi.org/10.1001/archpsyc.64.4.442
First MB, Fochtmann LJ. Treating Bipolar Disorder-A Quick Reference Guide. 2nd ed. Arlington, VA: American Psychiatric Association. 2002:170-189
Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations form the British Association for Psychopharmacology. J Psychopharmacol. 2016; 30(6):495-553. https://doi.org/10.1177/0269881116636545
. Malhi GS, Tanious M, Das P, Berk M. The science and practice of lithium therapy. Aust N Z J Psychiatry. 2012; 46(3):192-211. https://doi.org/10.1177/0004867412437346
. Grunze H, Vieta E, Goodwin GM, et al. WFSBP Task Force on Treatment Guidelines for Biopolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013; 14(3):154-219. https://doi.org/10.3109/15622975.2013.770551
US Food and Drug Administration. Approved Drug Products. Washington, DC: US Department of Health and Human Services. 2017.
Malhi GS, Gershon S. Ion men and their mettle. Aust N Z J Psychiatry. 2009; 43(12):1091-1095. https://doi.org/10.3109/00048670903279929
van Erp TG, Thompson PM, Kieseppä T, et al. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum Brain Mapp. 2012; 33(3):501-510. https://doi.org/10.1002/hbm.21239
Lithium [package insert]. Columbus, OH: Roxane Laboratories. 2011.
Abreu LN, Lafer B, Baca-Garcia E, Oquendo MA. Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Rev Bras Psiquiatr. 2009; 31(3):271-280. https://doi.org/10.1590/S1516-44462009005000003
DRUGDEX System (2.0). Greenwood Village, CO: Truven Health Analytics. Available at: http://www.micromedexsolutions.com [cited: Aug, 2022] .
Sameer Jauhar and Allan H. Young Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. 2019; 7:10 https://doi.org/10.1186/s40345-019-0145-0
Stay Hyun Kyung Lee , Shruti Prabhudesai , Ramu Vadukapuram , Noha Eskander , Rikinkumar S. Patel. Combination Regimen With Lithium and Antipsychotic in Bipolar Manic Episodes: Impact on Adult Hospitalization Length of Stay. Cureus.2020; 12(6):1-9
Miguélez Rodríguez A and Pérez de Mendiola Etxezarraga X. Lithium plus Olanzapine as One of the Most Effective Combinations for Bipolar Disorder. A Case Report and a Concise Review of the Literature. 2021; 3(1):65-69 https://doi.org/10.36959/784/427
Shoja Shafti S, Mood Stabilizer Vs Third Generation Antipsychotic: A Double-Blind Clinical Trial in Acute Mania. Int J Conf Proc. 2(2). https://doi.org/10.31031/ICP.2020.02.000533
Harald Scherk, MD; Frank Gerald Pajonk, MD, PhD; Stefan Leucht. Second-Generation Antipsychotic Agents in the Treatment of Acute Mania. 2007; 64:443-455 https://doi.org/10.1001/archpsyc.64.4.442
Yang Liu, Jun Liang, Qingrong Xia, Xin Zhou, Xuefeng Xie. Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China. Neuropsychiatric Disease and Treatment. 2020; 16:2623-2632 https://doi.org/10.2147/NDT.S270596
Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018; 20:97-170. https://doi.org/10.1111/bdi.12609
Geoffroy PA, Etain B, Henry C, Bellivier F. Combination therapy for manic phases: a critical review of a common practice. CNS Neurosci Ther. 2012; 18:957-964. https://doi.org/10.1111/cns.12017
Lin D, Mok H, Yatham LN. Polytherapy in bipolar disorder. CNS Drugs. 2006; 20:29-42 https://doi.org/10.2165/00023210-200620010-00003
Chengappa KN, Suppes T, Berk M. Treatment of bipolar mania with atypical antipsychotics . Expert Rev Neurother. 2004; 4:17-25. https://doi.org/10.1586/14737175.4.6.S17
Gianfrancesco F, Rajagopalan K, Goldberg JF, Wang RH. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications. Bipolar Disord. 2007; 9:252-261. https://doi.org/10.1111/j.1399-5618.2007.00394.x
Yatham LN, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry. 2005; 66:40-48.
Hyun S, Lee K, Prabhudesai S, Vadukapuram R, Eskander N, Patel RS. Combination Regimen With Lithium and Antipsychotic in Bipolar Manic Episodes. Impact on Adult Hospitalization Length of Stay. Cureus.2020; 12(6):1-9.
Published
Abstract Display: 458 
PDF Downloads: 484 PDF Downloads: 145 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.